Sustainability Investors Products Research & Development Company Contact
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies Clinical Trial Unit
Company
About us Our technology Operations Management Board of directors Awards
Contact
Sales Investor relations Factories Management
Type and search

All notices

JON OLAV ØDEGÅRD APPOINTED NEW CEO OF HBC

29.07.2022

NOTIFIABLE TRANSACTION – REDELIVERY OF SHARES

18.07.2022

DISCLOSURE OF LARGE SHAREHOLDING – AQUA-SPARK

03.07.2022

NOTIFIABLE TRANSACTIONS IN CONNECTION WITH PRIVATE PLACEMENT

03.07.2022

PRIVATE PLACEMENT SUCCESSFULLY PLACED

03.07.2022

CONTEMPLATED PRIVATE PLACEMENT

01.07.2022

CORRECTION: MANDATORY NOTIFICATION OF TRADE

06.05.2022

MANDATORY NOTIFICATION OF TRADE

06.05.2022

FIRST QUARTER 2022 FINANCIAL REPORT

06.05.2022

APPROVAL OF NEW SHARE INCENTIVE PROGRAM FOR CONSULTANTS – MANDATORY NOTIFICATION OF TRADE

29.04.2022

Previous
1
2 3 4
...
31
Next
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies Clinical Trial Unit
Company
About us Our technology Operations Management Board of directors Awards
Contact
Sales Investor relations Factories Management

Copyright 2021 Hofseth BioCare ASA
Privacy cookies